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The restricted tissue tropism observed in poliovirus infection is not governed solely by the expression of the poliovirus
receptor (PVR) gene, but might be controlled at stages beyond virus entry, such as translation, replication, or assembly.
Translation of poliovirus RNA by a cap-independent mechanism requires interactions of the 5*-untranslated region (5*UTR)
with cell proteins. To determine whether the patterns of these interacting proteins differ in HeLa cells and permissive and
nonpermissive tissues, UV-crosslinking assays using the poliovirus 5*UTR and tissue extracts from PVR transgenic mice
were performed. The results indicate a correlation between the presence of a 97-kDa UV-crosslinked protein and permissivity
to poliovirus infection. Acquired poliovirus susceptibility in in vitro-cultured kidney cells also correlates with the presence
of a 97-kDa crosslinked band. The interaction of the 97-kDa protein from HeLa cells and mouse brain with the poliovirus
5*UTR is stable and specific. Whether the 97-kDa protein plays a role in poliovirus translation and tissue susceptibility
remains to be determined. q 1997 Academic Press
Poliomyelitis is an acute disease of the central nervous one cycle of replication in many receptor-negative mam-
malian cell types (7). However, in PVR transgenic micesystem caused by poliovirus, a human enteric virus of
the Picornaviridae family (1). Most polioviruses have a (TgPVR), which express PVR in a wide range of tissues,
replication of poliovirus is detected only at a few loca-distinct species tropism and only infect primates, where
infection is transmitted by the oral–fecal route (2). After tions, including neurons of the brain and spinal cord,
skeletal muscle, and occasionally brown adipose cellsingestion, poliovirus replicates first in the oropharyngeal
and intestinal mucosa. Virus is shed into the gut lumen, (8, 9). Although viral replication is not detected in a variety
of other tissues from the same animals such as thymus,leading to virus in the feces, and a transient viremia
occurs. Disseminated virus then replicates in extraneural adrenal gland, intestine, and kidney, these tissues can
bind poliovirus (10). Despite expression of PVR RNA andtissues, such as skeletal muscle and brown adipose tis-
sue, which may be important in maintaining a persisting poliovirus binding sites, many TgPVR mouse tissues re-
main refractory to poliovirus infection, indicating that tis-viremia (3, 4). Transmission of virus into the central ner-
vous system (CNS), which takes place in approximately sue tropism in this animal model is not governed solely
by expression of the PVR gene (9).1% of infections, may occur via peripheral nerves or gan-
glia by axonal transport or through the blood–brain bar- The nature of the internal block to poliovirus infection
in nonsusceptible TgPVR mouse tissues, and in severalrier (5, 6).
Poliovirus replication is restricted to few tissues in established human blood cell lines in which viral replica-
tion differs depending on the differentiation stage andprimates. It has been suggested that the cellular poliovi-
rus receptor (PVR) is the major determining factor in cell cell lineage (11), has not been identified. It has been
suggested that poliovirus replication in those cells andand tissue susceptibility, since bypassing the receptor
binding step by transfection with poliovirus RNA permits tissues might be controlled at stages beyond virus entry,
such as translation, replication, or assembly (12). The
possibility that poliovirus mRNA translates efficiently only
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than that in HeLa cells (14). The limiting translation fac-
tors in some translation systems such as wheat-germ
extracts, Xenopus oocyte extracts, and reticulocyte lysate
suggest that the restriction in poliovirus translation might
contribute in part to the tissue-specific replication of po-
liovirus (15). On the other hand, after cultivation of kidney
in vitro, these cells become permissive to poliovirus in-
fection (9). The basis of the acquired susceptibility to
poliovirus infection in these cells is unknown, but might
FIG. 1. UV-induced crosslinking analysis. (A) 32P-labeled RNAs repre-involve the induction of factors required in some of the
senting the complete 5*UTR RNA nt 1–730 (lane 1) and a sequenceviral processes mentioned above (9). consisting of nt 275 to 628 (lane 2) from poliovirus type 3 were UV-
Translation of poliovirus RNA, which is one of the first crosslinked with 30 mg of S10 from HeLa cells. (B) 32P-labeled RNA
steps in poliovirus replication, occurs by internal ribo- representing nt 275 to 628 from poliovirus type 3 was UV-crosslinked
with 30 mg of S10 from HeLa cells (lane 1), mouse brain (lane 2),some entry (16). This process is believed to require the
skeletal muscle (lane 3), in vitro-cultured kidney cells (lane 4), kidneycanonical set of translation factors as well as other cell
(lane 5), and thymus (lane 6). Proteins were fractionated by 10% SDS–proteins that interact with the IRES (internal ribosome PAGE. Positions of molecular weight markers are shown on the right.
entry site) within the 5*-untranslated region (5*UTR) (17 – The 97-, 57/60-, and 52-kDa proteins are indicated at left.
22). To determine whether there are differences in the
interactions of such factors with the 5*UTR in permissive
and nonpermissive tissues, UV-crosslinking assays were RNAs were preincubated with the cell extract for 15
min, then labeled RNA was added and the mixture wasperformed. To produce linear templates for runoff tran-
scription, plasmids pFL-64 containing the complete incubated for 15 min prior to the crosslinking reaction.
When the UV-crosslinking assay was performed withcDNA sequence of the poliovirus type 3 5*UTR was
cleaved with EcoRV [nucleotide (nt) 730], and pPV-275 a HeLa S10 extract, proteins of 130, 110, 97, 80, 72, 68,
57/60, 52, and 38 kDa were crosslinked to the completecontaining the cDNA sequence of 275 to 672 with BalI
(nt 628) and PvuII (nt 488). Heterologous unlabeled RNA poliovirus 5*UTR (nt 1–730) (Fig. 1A, lane 1). A similar
pattern of crosslinked proteins was observed when awas obtained after transcription of Bluescript cleaved
with PvuII (nt 977). Labeled RNAs were prepared by in shorter RNA (nt 275–628), which contains the major ele-
ment that confers cap-independent translation to poliovi-vitro transcription of pFL-64 and pPV-275 in the presence
of [a-32P]UTP as described (17). Transcription reaction rus mRNA (nt 320 to 620) (19) was used (Fig. 1A, lane
2). The 80-, 72-, and 68-kDa proteins crosslinked at highermixes were treated with DNAse RQ1 (Promega) at 377
for 15 min, and unincorporated nucleotides were re- levels with the complete 5*UTR, while the 130- and 57/
60-kDa proteins crosslinked at lower levels compared tomoved by centrifugation in Sepharose G50 columns.
In vitro cultivation of transgenic mouse kidney was crosslinking with the 275–628 RNA (Fig. 1A, lanes 1 and
2). The variation in the crosslinking of these proteinsperformed as previously described (9). S10 extracts
from HeLa and permissive kidney cultures were pre- might result from different conformations adopted by both
RNAs. This result indicates that the same proteins bindpared as described (18). To prepare S10 extracts from
tissues, 5-week-old TgPVR mice were sacrificed, and to the complete 5*UTR and to sequences between nt
275 and 628, a region that also confers cap-independentbrain, skeletal muscle from the posterior limbs, thy-
mus, and kidney were removed and placed in cold translation of a reporter gene (19, 20). The nt 275–628
RNA was therefore used for subsequent experiments.PBS. Each organ was cut into small pieces and washed
in five volumes of a cold solution of 10 mM HEPES, To determine whether there are differences in the in-
teractions of cell proteins from permissive and nonper-pH 7.9, 1.5 mM MgCl2 , and 10 mM KCl. Tissues were
homogenized and cells were broken on ice in a dounce missive tissues with the 5*UTR, UV-crosslinking assays
were performed with extracts prepared from differenthomogenizer in the presence of two cell volumes of the
same cold buffer with 11 protease inhibitor cocktail (2 TgPVR mouse tissues. Five proteins of molecular weights
97, 80, 68, 40, and 38 kDa from brain extract were cross-mM EDTA, 0.5 mM PMSF, 2 mM benzomidine, 5 mg/
ml aprotinin, 5 mg/ml pepstatin, 5 mg/ml leupeptin, and linked with the 32P-labeled RNA probe (Fig. 1B, lane 2).
A doublet of 57/60 kDa was also observed after overex-5 mg/ml chemostatin). The homogenate was centri-
fuged at 10,000 rpm in a Sorvall GSA rotor at 47 for 30 posure of the membrane. Five crosslinked proteins of 97,
80, 57, 52, and 42 kDa were detected when muscle ex-min, the supernatant was divided into aliquots, and
the protein concentration was determined using the tract was used (Fig. 1B, lane 3), while proteins of 70, 52,
and 42 kDa were detected when kidney extract was usedBradford reaction. UV-crosslinking assays were per-
formed at 47 as previously described (18) in the pres- (Fig. 1B, lane 5). When thymus extracts were used, cross-
linked proteins of 68, 56/54, 52, and 42 kDa were de-ence of 11 protease inhibitor cocktail, at 0, 300, 600, or
900 mM KCl. For competition experiments, unlabeled tected (Fig. 1B, lane 6).
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reduced in the presence of 300 mM KCl, while the 57/
60-kDa protein was reduced but to a lesser extent. None
of the other interactions were disrupted. At 600 mM KCl,
the interaction of the 97-, 70-, and 57/60-kDa proteins
was significantly reduced. The 52-kDa protein was de-
tected up to 900 mM KCl, although at lower levels. These
results indicate that the interaction of the 97-, 70-, 57/60-,
and 52-kDa proteins with the 5*UTR is stable in 300 mM
salt. Similar experiments were also conducted to deter-
FIG. 2. Specificity of UV-crosslinking. Labeled poliovirus RNA (nt mine whether the interaction of the 97-kDa protein from
275 –628) was incubated with 30 mg of S10 from HeLa cells without mouse brain was also salt resistant (Fig. 3B). The interac-
competitor (lane 1) or in the presence of a 50-fold molar excess of
tion of the 80- and 68-kDa proteins was strongly reducedunlabeled RNAs of poliovirus type 3 consisting of nt 1–730 (lane 2), nt
in the presence of 300 mM KCl, while none of the other275 –628 (lane 3), or nt 275–488 (lane 4), or a 50-fold molar excess of
unlabeled heterologous Bluescript RNA (lane 5). Positions of molecular protein interactions were disrupted (Fig. 3B, lane 2). The
weight markers are shown on the right. The 97-, 57/60-, and 52-kDa 97- and 38-kDa proteins from mouse brain tissue inter-
proteins are indicated at left. acted with the poliovirus 5*UTR at 300 mM KCl. At 600
mM KCl, the interaction of all crosslinked proteins was
disrupted (Fig. 3B, lane 3). Although these results do notThese results show that a 97-kDa protein crosslinked
poorly or not at all when extracts from the nonpermissive show that the 97-kDa crosslinked proteins from different
tissues and from HeLa cells are the same protein, theytissues kidney and thymus were used (Fig. 1B, lanes 5
and 6) while the 97-kDa protein crosslinked at signifi- clearly share some characteristics, such as molecular
weight, the ability to crosslink with nt 275–628 of poliovi-cantly higher levels when extracts from HeLa cells, brain,
muscle, and kidney cell culture, all of which are permis- rus RNA, specificity of binding, and stability in 300 mM
salt.sive for poliovirus infection, were used (Fig. 1B, lanes 1, 2,
3, and 4, respectively). Our results suggest a correlation Cell proteins of 100 and 110 kDa (p100 and p110) have
been detected crosslinked to the poliovirus 5*UTR (21).between the presence of a 97-kDa protein that can be
UV-crosslinked to the poliovirus 5*UTR and permissivity A protein of 97 kDa, which is specifically crosslinked to
the rhinovirus 5*UTR, has been found to act synergisti-of TgPVR tissues to poliovirus infection.
To provide information on the binding site of the 97- cally with another cell protein, pPTB, to stimulate cap-
independent translation directed by the rhinovirus IRESkDa protein within the poliovirus 5*UTR and its speci-
ficity, competition experiments with homologous and (22). Because of the similarities in primary sequences
and in secondary structures within the IRES elements ofheterologous RNAs were performed in HeLa extracts
(Fig. 2). A 50-fold molar excess of homologous RNA poliovirus and rhinovirus, it is possible that they have
similar requirements for initiation factors (18). In supportfrom nt 1 – 730 or nt 275 – 628 strongly reduced the lev-
els of all crosslinked proteins (Fig. 2, lanes 2 and 3), of this hypothesis, RNA consisting of nt 275–628 from
the poliovirus 5*UTR inhibits complex formation with ntbut a 50-fold molar excess of heterologous unlabeled
RNA was an inefficient competitor (Fig. 2, lane 5), dem- 343–636 from HRV14, suggesting that some of the same
cellular factors, including a 97-kDa protein, are bound byonstrating that the crosslinking of all the observed pro-
teins, including the 97-kDa protein, with nt 275 – 628 of the two different viral sequences (18). Since p97 has not
yet been identified, it is not known whether the 97-kDathe poliovirus 5*UTR is specific. To more precisely lo-
cate the 97-kDa protein binding site, an RNA consisting protein detected in our study is identical to p97 that inter-
of nt 275 – 488 was used as a competitor (Fig. 2, lane
4). This RNA strongly reduced crosslinking of the 70-,
68-, and 57/60-kDa proteins, suggesting that they bind
to the nt 275 – 488 sequence. The interaction of the 97-
and 52-kDa proteins was also reduced but to a lesser
extent, suggesting that they interact with a sequence
within nt 275 – 488 and may have additional binding
sites within nt 488 – 628.
The stability of the complexes was examined by incu-
bating HeLa cell extracts with different salt concentra-
tions prior to UV-crosslinking. Labeled RNA from nt 275 –
FIG. 3. Stability of UV-crosslinking. Labeled poliovirus RNA (nt 275–628 was incubated with 30 mg of HeLa S10 extract in
628) was incubated with 30 mg of S10 extract from HeLa (A) and brain
the presence of 0, 300, 600, and 900 mM KCl (Fig. 3A, (B) in the absence (lane 1) or in the presence of 300, 600, and 900 mM
lanes 1, 2, 3, and 4, respectively). The interaction of the KCl (lanes 2, 3, and 4, respectively). Positions of molecular weight
markers are shown at left.110-, 68-, and 38-kDa crosslinked proteins was strongly
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